Song J, Ren W, Xu T, Zhang Y, Guo H, Zhu S, & Yang L. (2017). Reversal of multidrug resistance in human lung cancer cells by delivery of 3-octadecylcarbamoylacrylic acid–cisplatin-based liposomes. Dove Medical Press.
Chicago Style (17th ed.) CitationSong J, Ren W, Xu T, Zhang Y, Guo H, Zhu S, and Yang L. Reversal of Multidrug Resistance in Human Lung Cancer Cells by Delivery of 3-octadecylcarbamoylacrylic Acid–cisplatin-based Liposomes. Dove Medical Press, 2017.
MLA (9th ed.) CitationSong J, et al. Reversal of Multidrug Resistance in Human Lung Cancer Cells by Delivery of 3-octadecylcarbamoylacrylic Acid–cisplatin-based Liposomes. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.